DaVita Inc. to Participate in UBS Global Healthcare Conference 2024

Rhea-AI Summary

DaVita Inc. (NYSE: DVA) announced its participation in the UBS Global Healthcare Conference 2024 on November 12, 2024. CFO Joel Ackerman and Group VP of Investor Relations Nic Eliason will engage in a fireside chat at 12:30 pm PST.

DaVita is a leading kidney care provider serving 265,400 patients across 3,113 outpatient dialysis centers globally, with 2,660 centers in the United States and 453 centers in 13 other countries as of September 30, 2024. The company specializes in comprehensive kidney care services, from disease progression management to transplantation support and home dialysis, maintaining a 20-year track record of clinical excellence and innovation.

News Market Reaction – DVA

+3.22%

+3.22% Session move

In the trading session that priced this news, DVA gained 3.22%, reflecting a moderate positive market reaction.

Data tracked by StockTitan Argus on the day of publication.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

DENVER, Nov. 8, 2024 /PRNewswire/ -- DaVita Inc. (NYSE: DVA) today announced that its chief financial officer, Joel Ackerman, and its group vice president of investor relations, Nic Eliason, will participate in a fireside chat with investors at UBS Global Healthcare Conference 2024 on Tuesday, November 12, 2024 at 12:30 pm PST (3:30 pm EST).

To view the live webcast, visit the UBS page here and create a free registration.

About DaVita Inc.

DaVita (NYSE: DVA) is a health care provider focused on transforming care delivery to improve quality of life for patients globally. As a comprehensive kidney care provider, DaVita has been a leader in clinical quality and innovation for more than 20 years. DaVita cares for patients at every stage and setting along their kidney health journey—from slowing the progression of kidney disease to helping to support transplantation, from acute hospital care to dialysis at home. As of September 30, 2024, DaVita served approximately 265,400 patients at 3,113 outpatient dialysis centers, of which 2,660 centers were located in the United States and 453 centers were located in 13 other countries worldwide. DaVita has reduced hospitalizations, improved mortality, and worked collaboratively to propel the kidney care industry to adopt an equitable and high-quality standard of care for all patients, everywhere. To learn more, visit DaVita.com/About.

Contact Information
IR@davita.com

 

View original content to download multimedia:https://www.prnewswire.com/news-releases/davita-inc-to-participate-in-ubs-global-healthcare-conference-2024-302300393.html

SOURCE DaVita

FAQ

When is DaVita (DVA) presenting at the UBS Global Healthcare Conference 2024?

DaVita (DVA) will present at the UBS Global Healthcare Conference 2024 on Tuesday, November 12, 2024, at 12:30 pm PST (3:30 pm EST).

How many dialysis centers does DaVita (DVA) operate as of September 2024?

As of September 30, 2024, DaVita operates 3,113 outpatient dialysis centers, with 2,660 centers in the United States and 453 centers across 13 other countries.

How many patients does DaVita (DVA) serve globally?

As of September 30, 2024, DaVita serves approximately 265,400 patients globally through its network of outpatient dialysis centers.

Who will represent DaVita (DVA) at the UBS Global Healthcare Conference 2024?

DaVita will be represented by CFO Joel Ackerman and Group Vice President of Investor Relations Nic Eliason at the conference.